The U.S. Department of Defense plans to implement regular testosterone screening across its service members, despite explicit warnings from major medical organizations against this approach. The practice risks overtreatment and serious health consequences, including paradoxically suppressing the body's natural testosterone production.
Professional medical bodies, including the Endocrine Society and the American Urological Association, do not recommend routine testosterone screening in asymptomatic populations. These organizations reserve testing for individuals with specific symptoms of low testosterone, such as sexual dysfunction, fatigue, or mood changes.
The DoD's screening program could identify men with low-normal testosterone levels who have no clinical symptoms. This creates a pathway to unnecessary hormone replacement therapy, which carries documented risks. Men receiving testosterone treatment face increased rates of cardiovascular events, including heart attacks and strokes. Extended therapy can also suppress the hypothalamic-pituitary-gonadal axis, the body's natural testosterone-producing system. When men discontinue treatment, their endogenous testosterone production may remain impaired.
The military's rationale for screening appears rooted in assumptions about performance and readiness. Testosterone influences muscle mass, bone density, and mood. However, medical evidence does not support treating asymptomatic low testosterone in otherwise healthy men to improve these outcomes.
Experts worry that DoD screening will create a cohort of service members receiving long-term testosterone therapy without clear medical justification. This represents a departure from evidence-based medicine and exposes military personnel to preventable harm.
The policy reflects a broader challenge in military medicine: balancing operational readiness with individual health protection. Service members often face pressure to maintain peak physical condition, potentially creating incentives to pursue hormonal interventions even when medically unnecessary.
Medical organizations have developed clear guidelines for appropriate testosterone testing and treatment. The DoD's universal screening approach circumvents these standards and contradicts established endocrinological practice.